Serum GFAP – reference interval and preanalytical properties in Danish adults

Blood GFAP as an emerging biomarker in brain and spinal cord disorders

(2022) Ahmed Abdelhak et al.   Nature Reviews Neurology

Blood-Based Markers of Neuronal Injury in Adult-Onset Myotonic Dystrophy Type 1

(2022) Ellen van der Plas et al.   Frontiers in Neurology

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease

(2022) Joshua Stevenson-Hoare et al.   BRAIN

Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1

(2022) Zoë Y. G. J. van Lierop et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Short-term biological variation of serum glial fibrillary acidic protein

(2022) Silje Hovden Christensen et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

(2021) Pratishtha Chatterjee et al.   Translational Psychiatry

Prolonged elevation of serum neurofilament light after concussion in male Australian football players

(2021) Stuart J. McDonald et al.   Biomarker Research

Assessment of Blood Biomarker Profile After Acute Concussion During Combative Training Among US Military Cadets

(2021) Christopher C. Giza et al.   JAMA Network Open

Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

(2021) Orhan Aktas et al.   ANNALS OF NEUROLOGY

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

(2021) Patrick Schindler et al.   Journal of Neuroinflammation

Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis

(2021) Maija Saraste et al.   Multiple Sclerosis and Related Disorders

Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies

(2021) Xuechun Chang et al.   Frontiers in Immunology

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease

(2021) Joana B Pereira et al.   BRAIN

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group

(2021) Inge M. W. Verberk et al.   Alzheimers & Dementia

Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia

(2020) Carolin Heller et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults

(2020) Claus Vinter Bødker Hviid et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)

(2020) Michael Cornes et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Multiple smoothing parameters selection in additive regression quantiles

(2020) Vito M.R. Muggeo et al.   STATISTICAL MODELLING

Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity

(2020) Xavier Ayrignac et al.   Scientific Reports

Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study

(2020) Endre Czeiter et al.   EBioMedicine

Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage

(2020) Breton M. Asken et al.   JOURNAL OF ALZHEIMERS DISEASE

Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration

(2020) Alberto Benussi et al.   JOURNAL OF ALZHEIMERS DISEASE

Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study

(2020) David O. Okonkwo et al.   JOURNAL OF NEUROTRAUMA

Biomarkers of Neurological Outcome After Aneurysmal Subarachnoid Hemorrhage as Early Predictors at Discharge from an Intensive Care Unit

(2020) Jaroslaw Kedziora et al.   Neurocritical Care

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

(2020) Inge M. W. Verberk et al.   Alzheimers Research & Therapy

Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults

(2020) Nathan A. Huebschmann et al.   Frontiers in Neurology

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment

(2019) Patrick Oeckl et al.   JOURNAL OF ALZHEIMERS DISEASE

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

(2019) Ahmed Abdelhak et al.   Frontiers in Neurology

Stability of Blood Biomarkers of Traumatic Brain Injury

(2019) Paymon Garakani Rezaii et al.   JOURNAL OF NEUROTRAUMA

Glial fibrillary acidic protein as a prognostic marker of acute ischemic stroke

(2018) G Liu et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Performance Evaluation of a Multiplex Assay for Simultaneous Detection of Four Clinically Relevant TBI Biomarkers

(2018) Frederick Kofi Korley et al.   JOURNAL OF NEUROTRAUMA

Post-mortem in situ stability of serum markers of cerebral damage and acute phase response

(2018) Benjamin Ondruschka et al.   INTERNATIONAL JOURNAL OF LEGAL MEDICINE

Serum GFAP as a biomarker for disease severity in multiple sclerosis

(2018) A. Abdelhak et al.   Scientific Reports

Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity

(2018) Heidi Högel et al.   Multiple Sclerosis Journal

Plasma Markers of Neurodegeneration Are Raised in Friedreich’s Ataxia

(2018) Anna M. Zeitlberger et al.   Frontiers in Cellular Neuroscience

Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease

(2015) Axel Petzold   BRAIN RESEARCH

Estimating growth charts via nonparametric quantile regression: a practical framework with application in ecology

(2012) Vito M. R. Muggeo et al.   ENVIRONMENTAL AND ECOLOGICAL STATISTICS

 -Amyloid burden in healthy aging: Regional distribution and cognitive consequences

(2012) K. M. Rodrigue et al.   NEUROLOGY